2900 – 550 Burrard Street
Vancouver, BC V6C 0A3
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11
|Mr. Benjamin Lightburn||Co-Founder, CEO & Director||134.79k||N/A||1987|
|Mr. Tom Kineshanko||Co-Founder||134.79k||N/A||1985|
|Mr. Warren Duncan||Chief Financial Officer||115.54k||N/A||1991|
|Mr. Jon Conlin||Corp. Sec. & Director||N/A||N/A||1986|
|Ms. Lisa Ranken||Chief Operating Officer||N/A||N/A||1984|
|Mr. Ryan Moss||Chief Science Officer||N/A||N/A||N/A|
|Ms. Anna Cordon||Director of Communications||N/A||N/A||N/A|
|Mr. Jeff Fellows||Head of Regulatory||N/A||N/A||N/A|
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.